Swedish Pharmaceutical Company Medivir AB (MVRBF) Chooses Certara Corporation’s D360 As Its Global Drug Discovery Platform
1/27/2014 9:34:46 AM
ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Medivir AB, a Swedish pharmaceutical company that focuses on infectious diseases including hepatitis C, has selected D360 as its global drug discovery platform. Certara’s D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. Medivir will use D360 to deliver research data and analytic tools to its discovery chemists and biologists in Stockholm, Sweden, and Cambridge, UK. The information will be sourced from its existing repository of chemical structure and biological assay data.
Help employers find you! Check out all the jobs and post your resume.
comments powered by